Tenn. Code Ann. § 39-17-404: Name of drug
Where this section sits in the code
- TN Code
- Title 39
- Chapter 17
(a) The controlled substances listed or to be listed in the schedules in this part are included by whatever official, common, usual, chemical, or trade name designated. (b) Notwithstanding any law to the contrary, the following are excluded from all schedules: (1) Non-narcotic substances excluded under 21 CFR 1308.22 , as amended; (2) Chemical preparations exempted under 21 CFR 1308.24 , as amended; (3) Veterinary anabolic steroid implant products excluded under 21 CFR 1308.26 , as amended; (4) Prescription products exempted under 21 CFR 1308.32 , as amended; (5) Anabolic steroid products exempted under 21 CFR 1308.34 , as amended; and (6) Certain cannabis plant material, and products made from such material, that contain tetrahydrocannabinols and that are exempted under 21 CFR 1308.35 , as amended. Amended by 2018 Tenn. Acts, ch. 1040,s 2, eff. 7/1/2018. Acts 1989, ch. 591, § 1.
(a) The controlled substances listed or to be listed in the schedules in this part are included by whatever official, common, usual, chemical, or trade name designated.
(b) Notwithstanding any law to the contrary, the following are excluded from all schedules: (1) Non-narcotic substances excluded under 21 CFR 1308.22 , as amended; (2) Chemical preparations exempted under 21 CFR 1308.24 , as amended; (3) Veterinary anabolic steroid implant products excluded under 21 CFR 1308.26 , as amended; (4) Prescription products exempted under 21 CFR 1308.32 , as amended; (5) Anabolic steroid products exempted under 21 CFR 1308.34 , as amended; and (6) Certain cannabis plant material, and products made from such material, that contain tetrahydrocannabinols and that are exempted under 21 CFR 1308.35 , as amended.
(1) Non-narcotic substances excluded under 21 CFR 1308.22 , as amended;
(2) Chemical preparations exempted under 21 CFR 1308.24 , as amended;
(3) Veterinary anabolic steroid implant products excluded under 21 CFR 1308.26 , as amended;
(4) Prescription products exempted under 21 CFR 1308.32 , as amended;
(5) Anabolic steroid products exempted under 21 CFR 1308.34 , as amended; and
(6) Certain cannabis plant material, and products made from such material, that contain tetrahydrocannabinols and that are exempted under 21 CFR 1308.35 , as amended.
Collected 2026-09-14T18:32:26Z. Source file · JSON